ROCKVILLE, Md. — Recognizing the benefits of proximity to leading U.S. researchers, regulators and advocacy groups, Nobelpharma America, LLC has chosen Montgomery County, Maryland as the location for its first overseas subsidiary of Nobelpharma Co. Ltd., a company headquartered in Tokyo, Japan. Nobelpharma’s company mission is to contribute to society by providing critical but neglected pharmaceuticals and medical devices.
Nobelpharma meets an essential patient need: it develops curative drugs and medical devices for diseases that often go overlooked because of the small number of patients. Examples include patients suffering from tuberous sclerosis complex (TSC) and adductor spasmodic dysphonia.
{iframe}https://thinkmoco.com/press-releases/nobelpharma?utm_source=MCEDC+Newsletter&utm_campaign=f3d1e3412e-EMAIL_CAMPAIGN_090320&utm_medium=email&utm_term=0_2ec33b29cd-f3d1e3412e-67973863&mc_cid=f3d1e3412e{/iframe}